X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217937
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-november-15-2023-17266.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-arm-gets-usfda-nod-for-generic-mycophenolate-mofetil-oral-suspension/articleshow/103203898.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214871
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214525
https://endpts.com/fda-requests-additional-time-for-flexions-snda-genentech-releases-data-for-phiii-study-of-rituxan/
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-15-2019-1557900358.pdf
https://www.pharmacompass.com/pdf/news/par-pharmaceutical-recalls-mycophenolate-mofetil-injection-usp-1556949713.pdf
https://www.prnewswire.com/news-releases/par-pharmaceutical-inc-issues-voluntary-nationwide-recall-of-one-lot-of-mycophenolate-mofetil-for-injection-usp-due-to-the-presence-of-a-glass-fragment-observed-in-one-vial-of-reconstituted-product-300842285.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210370
https://www.ema.europa.eu/documents/procedural-steps-after/praluent-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
https://www.pharmacompass.com/pdf/news/gattex-teduglutide-amlodipine-and-valsartan-tabs-shire-nps-pharm-v-par-pharma-et-al-1533038693.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204077
http://www.fiercepharmaasia.com/story/japans-mhlw-slated-review-nippon-boehringer-high-blood-pressure-combo/2016-04-13
http://www.medpagetoday.com/Rheumatology/GeneralRheumatology/50829
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/56690a-eng.php
http://www.vancpharm.com/wp-content/uploads/2014/12/2014-12-16-News-Release-announcing-additional-molecules.pdf
Market Place
Share 
